BONJELA MOUTH ULCER & TEETHING GEL choline salicylate 87 mg/g tube

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

choline salicylate, Quantity: 8.714 % w/w

Available from:

Reckitt Benckiser Pty Ltd

INN (International Name):

choline salicylate

Pharmaceutical form:

Gel

Composition:

Excipient Ingredients: Star anise oil; glycerol; purified water; saccharin sodium; hypromellose; cetalkonium chloride; menthol; ethanol

Administration route:

Buccal

Units in package:

15 g (until 30 Sep 2023), 15 g (on or after 1 Oct 2023)

Prescription type:

Not scheduled. Not considered by committee, (S2) Pharmacy Medicine

Therapeutic indications:

Provides fast-acting, soothing relief from the pain and discomfort associated with infant teething disorders, mouth ulcers and sores, and new dentures.

Product summary:

Visual Identification: Almost colourlesss viscous gel; Container Type: Tube; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2005-08-08